Hutch News
Results per Page:
“Why doesn’t cancer metastasize to your muscles?”
From the Ghajar Lab, Breast & Ovary Cancer Program, Cancer Consortium
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Genomic attributes predict cancer treatment responsiveness
From the Nelson Lab, Human Biology & Clinical Research Divisions
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Exercise video series for prostate cancer patients launches
A new resource designed to help improve patients’ overall quality of life
Black men with early-stage prostate cancer can do active surveillance
New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
US cancer death rate has declined for at least 25 years
Fred Hutch experts weigh in on milestone report from American Cancer Society
Dr. Joachim Deeg named Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair for Cancer Research
Endowment will support future research for myelodysplastic syndromes
Rolling up the miles for cancer research
Obliteride riders, walkers top $2 million in Fred Hutch fundraiser
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Overcoming androgen therapy resistance in prostate cancer
From the Peter Nelson Lab, Human Biology Division
'Movember' a reminder for dudes to go to the doctor
Growing facial hair in November part of spotlight on men’s health awareness — and the lack thereof
Targeted therapies push metastatic prostate cancer in new directions
Combination therapy could help stave off new “escape variant” of disease that arises in response to powerful treatments
Removing barriers to precision treatment of metastatic prostate cancer
GENTleMEN study aims to help men with advanced disease access genetic testing and counseling
Good News: NCI awards Dr. Ruth Etzioni 5-year grant to fill gaps in cancer-recurrence data
Celebrating faculty and staff achievements
The path to precision screening for cancer
For now, early detection of breast and prostate cancer means mammograms and PSAs, but a more tailored approach is on the horizon
Good News: Dr. Cyrus Ghajar receives $1M from Keck Foundation to study why cancer doesn’t spread to skeletal muscle
Celebrating faculty and staff achievements
Prostate cancer researcher cycles to save lives
Five-year Obliteride veteran Dr. Pete Nelson rides to make inroads against all cancers
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch